Mar 10,2022

Leben Salud becomes the first hospital to implement Kaiku Health in South America

Kaiku Health expansion around the world continues as Leben Salud becomes the first user of Kaiku Health in South America. The Argentinian hospital went live with Kaiku Health in November 2021 and currently uses the digital therapeutics platform in radiotherapy.

COLLABORATION PARTNERSHIP

#institution

#dtx

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

Oncology Peer Review On-The-Go: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial for NSCLC

CancerNetwork® recently spoke with Ofer Sharon, MD, chief executive officer of OncoHost, about interim results from the prospective PROPHETIC trial (NCT04056247) to potentially determine how patients with non–small cell lung cancer (NSCLC) respond to immunotherapy.

CLINICAL STUDY

#platform

#ai/software

View Analyst & Ambassador Comments
Go to original news
Mar 03,2022

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies

In this article in the scientific journal Blood Reviews, COTA researchers and collaborators share their views on the many sources of RWD and how to assess fit-for-purpose for use in RWE generation. They also review promising use cases for RWD, particularly for hematologic malignancies.

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 15,2022

Jasper Health Joins CEO Roundtable on Cancer

Jasper Health, a first-of-its-kind cancer care navigation and experience platform, today announced it will be joining the organization CEO Roundtable on Cancer. The CEO Roundtable on Cancer’s mission is to make continual progress toward the elimination of cancer as a personal disease and public health problem through initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies.

View Analyst & Ambassador Comments
Go to original news
Mar 16,2022

Driving Progress in Personalized Cancer Therapy

CEO of OncoHost, Ofer Sharon spoke with Technology Networks, to find out more about how OncoHost enables patient-specific treatment plans based on personalized medicine approaches.

View Analyst & Ambassador Comments
Go to original news
Mar 30,2022

Creating a Clear Path to Precision Oncology with Real-World Data

ViVE 2022 brought together thought leaders addressing key disparities and the future of healthcare. COTA's C.K. Wang, alongside expert oncologists and technology innovators stressed the need for understanding what “precision oncology” really is. On a panel of expert oncologists and technology innovators, COTA’s Chief Medical Officer, C.K. Wang, MD, stressed that the cancer care community must start their part of this journey with a better understanding of what “precision oncology” really is.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Apr 07,2022

Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries

As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Apr 08,2022

An AI Model may Predict Elevated Pancreatic Cancer Risk Using EHR

An artificial intelligence (AI) model trained using sequential health information derived from electronic health records (EHR) identified a subset of individuals with a 25-fold risk of developing pancreatic cancer within three to 36 months, according to results presented at the AACR Annual Meeting 2022, held April 8-13.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Apr 25,2022

Using AI to Detect Cancer from Patient Data Securely

The researchers set out to discover whether a form of AI, called swarm learning, could be used to help computers predict cancer in medical images of patient tissue samples, without releasing the data from hospitals.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Apr 21,2022

AI Helps Physicians Better Assess the Effectiveness of Bladder Cancer Treatment

In a small but multi-institutional study, an artificial intelligence (AI)-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder removal surgery). Yet the researchers caution that AI isn't a replacement for human expertise and that their tool shouldn’t be used as such. "If you use the tool smartly, it can help you," said Lubomir Hadjiyski, Ph.D., a professor of radiology at the University of Michigan Medical School and the senior author of the study.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY